Skip to content

New Stent Retriever, VERSI System for AIS

Efficacy and Safety of VERSI System for Acute Ischemic Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03366818
Enrollment
10
Registered
2017-12-08
Start date
2017-09-21
Completion date
2019-03-31
Last updated
2019-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Ischemic Stroke

Brief summary

To confirm efficacy and safety of VERSI system for acute ischemic stroke

Detailed description

Efficacy; TICI 2a or more recanalization upto 3 pass of study device Safety; symptomatic intracranial hemorrhage within 24 hours of procedure

Interventions

DEVICEthrombectomy

mechanical thrombectomy

Sponsors

Kobe City General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* onset to treat within 8 hours * NIHSS 8 or more * ASPECTS 5 or more * Target vessel is ICA, MCA, VA, BA, PCA * non-eligible or failed IV rt-PA

Exclusion criteria

* known hemorrhagic tendency * arterial dissection, vasculitis * allergy for contrast media * other inappropriate condition

Design outcomes

Primary

MeasureTime frameDescription
incidence of treatment-related severe adverse eventwithin 24 hours after proceduresymptomatic intracranial hemorrhage

Secondary

MeasureTime frameDescription
recovery to independent life {modified Rankin score of 2 or less]90days after procedureProportion of subjects who have modified Rankin Scale (mRS) score of 2 or less
all intracralnial hemorrhagewithin 24 hours after procedureincidence of symptomatic and asymptomatic intracranial hemorrhage
acceptable clinical outcome90days after procedureProportion of subjects who have modified Rankin Scale (mRS) score of 2 or less or back to baseline of mRS
Severe adverse event related to devicewithin 24 hours after procedureAny severe adverse event related to device
recanalization ability of deviceimmediatry after procedurerate of immediate reperfusion with the device upto 3 path measured using Thrombolysis in Cerebrovascular Infarction (TICI) score of 2b or greater

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026